Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.71 USD | -0.05% | +1.02% | +9.93% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.93% | 5.17B | |
+2.73% | 108B | |
+9.72% | 104B | |
+6.58% | 23.66B | |
-12.61% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.16% | 16.19B | |
+4.37% | 13.72B | |
+34.35% | 12.22B |
- Stock
- Equities
- Stock Halozyme Therapeutics, Inc. - Nasdaq
- News Halozyme Therapeutics, Inc.
- Halozyme Therapeutics Q4 Adjusted EPS, Revenue Decline; FY2022 Guidance Reiterated